{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:29:44Z","timestamp":1794266984539,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Calcific aortic valve disease (CAVD) is a prevalent valvular disorder that lacks effective pharmacological treatments. Metformin, an oral anti-diabetic drug, has been suggested to protect valvular interstitial cells (VICs) from calcification, but its role in preventing organic phosphate-induced degeneration in VICs and aortic valve (AV) leaflets remains unclear. Using an ex vivo three-dimensional tissue model, we induced degeneration with organic phosphate-rich conditions in ovine VICs and AV leaflets. Metformin treatment reduced calcium deposition, as assessed by alizarin red staining (VICs:\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001; AV leaflets:\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05), and preserved reduced opacity of AV leaflet (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01). It inhibited early osteogenic differentiation, evidenced by reduced alkaline phosphatase activity (VICs:\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001; AV leaflets:\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05), and mitigated gene expression of myofibroblastic markers. Furthermore, metformin improved proliferation (VICs:\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001; AV leaflets:\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05), lowered lactate dehydrogenase levels (VICs:\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01; AV leaflets:\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), preserved extracellular matrix architecture, and ameliorated extracellular matrix remodeling at gene expression level. AMPK phosphorylation was increased in both VICs (28%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and AV leaflets (21%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05) under pro-degenerative conditions and metformin treatment. In conclusion, metformin protects against organic phosphate-induced degeneration in both VICs and AV leaflets, highlighting its therapeutic potential in CAVD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-31070-6","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:26:10Z","timestamp":1765995970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metformin mitigates aortic valve degeneration in an ex vivo three-dimensional tissue model"],"prefix":"10.1038","volume":"15","author":[{"given":"Friederike Irmgard","family":"Schoettler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian Johannes","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz Benjamin","family":"Immohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Lichtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Akhyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"31070_CR1","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","volume":"2","author":"BR Lindman","year":"2016","unstructured":"Lindman, B. R. et al. Calcific aortic stenosis. Nat. Rev. Dis. Primers. 2, 16006. https:\/\/doi.org\/10.1038\/nrdp.2016.6 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"31070_CR2","doi-asserted-by":"publisher","unstructured":"Donato, M., Ferri, N., Lupo, M. G., Faggin, E. & Rattazzi, M. Current evidence and future perspectives on Pharmacological treatment of calcific aortic valve stenosis. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21218263 (2020).","DOI":"10.3390\/ijms21218263"},{"key":"31070_CR3","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","volume":"63","author":"S Coffey","year":"2014","unstructured":"Coffey, S., Cox, B. & Williams, M. J. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 63, 2852\u20132861. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.018 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"31070_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/ehjqcco\/qcad018","volume":"9","author":"S Shu","year":"2023","unstructured":"Shu, S. et al. Alerting trends in epidemiology for calcific aortic valve disease, 1990\u20132019: an age-period-cohort analysis for the global burden of disease study 2019. Eur. Heart J. Qual. Care Clin. Outcomes. 9, 459\u2013473. https:\/\/doi.org\/10.1093\/ehjqcco\/qcad018 (2023).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"31070_CR5","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1093\/eurheartj\/ehx653","volume":"39","author":"F Peeters","year":"2018","unstructured":"Peeters, F. et al. Calcific aortic valve stenosis: hard disease in the heart: A biomolecular approach towards diagnosis and treatment. Eur. Heart J. 39, 2618\u20132624. https:\/\/doi.org\/10.1093\/eurheartj\/ehx653 (2018).","journal-title":"Eur. Heart J."},{"key":"31070_CR6","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1161\/ATVBAHA.114.302523","volume":"34","author":"KE Yutzey","year":"2014","unstructured":"Yutzey, K. E. et al. Calcific aortic valve disease: a consensus summary from the alliance of investigators on calcific aortic valve disease. Arterioscler. Thromb. Vasc Biol. 34, 2387\u20132393. https:\/\/doi.org\/10.1161\/ATVBAHA.114.302523 (2014).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"31070_CR7","doi-asserted-by":"publisher","unstructured":"Rajamannan, N. M. & agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Calcific aortic valve disease: not simply a degenerative process: A review and. Executive summary: Calcific aortic valve disease-2011 update. Circulation 124, 1783\u20131791, (2011). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.006767","DOI":"10.1161\/CIRCULATIONAHA.110.006767"},{"key":"31070_CR8","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1161\/01.ATV.0000227513.13697.ac","volume":"26","author":"KD O\u2019Brien","year":"2006","unstructured":"O\u2019Brien, K. D. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler. Thromb. Vasc Biol. 26, 1721\u20131728. https:\/\/doi.org\/10.1161\/01.ATV.0000227513.13697.ac (2006).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"31070_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-physiol-012110-142145","volume":"73","author":"RB Hinton","year":"2011","unstructured":"Hinton, R. B. & Yutzey, K. E. Heart valve structure and function in development and disease. Annu. Rev. Physiol. 73, 29\u201346. https:\/\/doi.org\/10.1146\/annurev-physiol-012110-142145 (2011).","journal-title":"Annu. Rev. Physiol."},{"key":"31070_CR10","doi-asserted-by":"publisher","unstructured":"Rutkovskiy, A. et al. Valve interstitial cells: the key to Understanding the pathophysiology of heart valve calcification. J. Am. Heart Assoc. 6 https:\/\/doi.org\/10.1161\/JAHA.117.006339 (2017).","DOI":"10.1161\/JAHA.117.006339"},{"key":"31070_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2353\/ajpath.2007.070251","volume":"171","author":"AC Liu","year":"2007","unstructured":"Liu, A. C., Joag, V. R. & Gotlieb, A. I. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am. J. Pathol. 171, 1407\u20131418. https:\/\/doi.org\/10.2353\/ajpath.2007.070251 (2007).","journal-title":"Am. J. Pathol."},{"key":"31070_CR12","first-page":"841","volume":"13","author":"E Rabkin-Aikawa","year":"2004","unstructured":"Rabkin-Aikawa, E., Farber, M., Aikawa, M. & Schoen, F. J. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J. Heart Valve Dis. 13, 841\u2013847 (2004).","journal-title":"J. Heart Valve Dis."},{"key":"31070_CR13","first-page":"449","volume":"20","author":"EL Monzack","year":"2011","unstructured":"Monzack, E. L. & Masters, K. S. Can valvular interstitial cells become true osteoblasts? A side-by-side comparison. J. Heart Valve Dis. 20, 449\u2013463 (2011).","journal-title":"J. Heart Valve Dis."},{"key":"31070_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian, A. et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 43, 561\u2013632. https:\/\/doi.org\/10.1093\/eurheartj\/ehab395 (2022).","journal-title":"Eur. Heart J."},{"key":"31070_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/eurheartj\/ehab757","volume":"43","author":"S Kraler","year":"2022","unstructured":"Kraler, S., Blaser, M. C., Aikawa, E., Camici, G. G. & Luscher, T. F. Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy. Eur. Heart J. 43, 683\u2013697. https:\/\/doi.org\/10.1093\/eurheartj\/ehab757 (2022).","journal-title":"Eur. Heart J."},{"key":"31070_CR16","doi-asserted-by":"publisher","unstructured":"Lutz, M. et al. Differences in the presentation and management of patients with severe aortic stenosis in different European centres. Open. Heart. 7 https:\/\/doi.org\/10.1136\/openhrt-2020-001345 (2020).","DOI":"10.1136\/openhrt-2020-001345"},{"key":"31070_CR17","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1016\/j.jacc.2021.09.1367","volume":"78","author":"BR Lindman","year":"2021","unstructured":"Lindman, B. R. et al. Evaluating medical therapy for calcific aortic stenosis: JACC State-of-the-Art review. J. Am. Coll. Cardiol. 78, 2354\u20132376. https:\/\/doi.org\/10.1016\/j.jacc.2021.09.1367 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"31070_CR18","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.2337\/dc23-S009","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed, N. A. et al. 9. Pharmacologic approaches to glycemic treatment: standards of care in Diabetes-2023. Diabetes Care. 46, S140\u2013S157. https:\/\/doi.org\/10.2337\/dc23-S009 (2023).","journal-title":"Diabetes Care"},{"key":"31070_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena, G., Hardie, D. G. & Pearson, E. R. The mechanisms of action of Metformin. Diabetologia 60, 1577\u20131585. https:\/\/doi.org\/10.1007\/s00125-017-4342-z (2017).","journal-title":"Diabetologia"},{"key":"31070_CR20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1124\/jpet.102.034140","volume":"302","author":"DS Wang","year":"2002","unstructured":"Wang, D. S. et al. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of Metformin. J. Pharmacol. Exp. Ther. 302, 510\u2013515. https:\/\/doi.org\/10.1124\/jpet.102.034140 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"31070_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cmet.2010.04.001","volume":"11","author":"SA Hawley","year":"2010","unstructured":"Hawley, S. A. et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell. Metab. 11, 554\u2013565. https:\/\/doi.org\/10.1016\/j.cmet.2010.04.001 (2010).","journal-title":"Cell. Metab."},{"key":"31070_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10522-023-10072-9","volume":"25","author":"A Salminen","year":"2024","unstructured":"Salminen, A. AMPK signaling inhibits the differentiation of myofibroblasts: impact on age-related tissue fibrosis and degeneration. Biogerontology 25, 83\u2013106. https:\/\/doi.org\/10.1007\/s10522-023-10072-9 (2024).","journal-title":"Biogerontology"},{"key":"31070_CR23","doi-asserted-by":"publisher","first-page":"670222","DOI":"10.3389\/fcvm.2021.670222","volume":"8","author":"Y Lu","year":"2021","unstructured":"Lu, Y., Yuan, T., Min, X., Yuan, Z. & Cai, Z. A. M. P. K. Potential therapeutic target for vascular calcification. Front. Cardiovasc. Med. 8, 670222. https:\/\/doi.org\/10.3389\/fcvm.2021.670222 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"Suppl 3","key":"31070_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/dom.15756","volume":"26","author":"JR Petrie","year":"2024","unstructured":"Petrie, J. R. Metformin beyond type 2 diabetes: emerging and potential new indications. Diabetes Obes. Metab. 26 (Suppl 3), 31\u201341. https:\/\/doi.org\/10.1111\/dom.15756 (2024).","journal-title":"Diabetes Obes. Metab."},{"key":"31070_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/FJC.0000000000000599","volume":"72","author":"C Driver","year":"2018","unstructured":"Driver, C. et al. Cardioprotective effects of Metformin. J. Cardiovasc. Pharmacol. 72, 121\u2013127. https:\/\/doi.org\/10.1097\/FJC.0000000000000599 (2018).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"31070_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s10020-021-00416-x","volume":"27","author":"Q En","year":"2021","unstructured":"En, Q., Zeping, H., Yuetang, W., Xu, W. & Wei, W. Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K\/AKT pathway in an AMPK dependent way. Mol. Med. 27, 156. https:\/\/doi.org\/10.1186\/s10020-021-00416-x (2021).","journal-title":"Mol. Med."},{"key":"31070_CR27","doi-asserted-by":"publisher","first-page":"21435","DOI":"10.1038\/s41598-023-47774-6","volume":"13","author":"K Phadwal","year":"2023","unstructured":"Phadwal, K., Tan, X., Koo, E., Zhu, D. & MacRae, V. E. Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux. Sci. Rep. 13, 21435. https:\/\/doi.org\/10.1038\/s41598-023-47774-6 (2023).","journal-title":"Sci. Rep."},{"key":"31070_CR28","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/biomedicines9050474","volume":"9","author":"A Weber","year":"2021","unstructured":"Weber, A. et al. Reproducible in vitro tissue culture model to study basic mechanisms of calcific aortic valve disease: comparative analysis to valvular interstitials cells. Biomedicines 9, 474 (2021).","journal-title":"Biomedicines"},{"key":"31070_CR29","doi-asserted-by":"publisher","unstructured":"Selig, J. I. et al. Crosstalk of diabetic conditions with static versus dynamic flow Environment-Impact on aortic valve remodeling. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22136976 (2021).","DOI":"10.3390\/ijms22136976"},{"key":"31070_CR30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.bbrc.2018.04.141","volume":"500","author":"F Liu","year":"2018","unstructured":"Liu, F. et al. Metformin ameliorates TGF-beta1-induced osteoblastic differentiation of human aortic valve interstitial cells by inhibiting beta-catenin signaling. Biochem. Biophys. Res. Commun. 500, 710\u2013716. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.141 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"31070_CR31","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/cvr\/cvab038","volume":"117","author":"M Back","year":"2021","unstructured":"Back, M. & Michel, J. B. From organic and inorganic phosphates to valvular and vascular calcifications. Cardiovasc. Res. 117, 2016\u20132029. https:\/\/doi.org\/10.1093\/cvr\/cvab038 (2021).","journal-title":"Cardiovasc. Res."},{"key":"31070_CR32","doi-asserted-by":"publisher","unstructured":"Goto, S. et al. Standardization of human calcific aortic valve disease in vitro modeling reveals Passage-Dependent calcification. Front. Cardiovasc. Med. 6 https:\/\/doi.org\/10.3389\/fcvm.2019.00049 (2019).","DOI":"10.3389\/fcvm.2019.00049"},{"key":"31070_CR33","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3389\/fphys.2018.01635","volume":"9","author":"M Bogdanova","year":"2018","unstructured":"Bogdanova, M. et al. Inflammation and mechanical stress stimulate osteogenic differentiation of human aortic valve interstitial cells. Front. Physiol. 9, 1635. https:\/\/doi.org\/10.3389\/fphys.2018.01635 (2018).","journal-title":"Front. Physiol."},{"key":"31070_CR34","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2353\/ajpath.2009.080750","volume":"174","author":"JH Chen","year":"2009","unstructured":"Chen, J. H., Yip, C. Y., Sone, E. D. & Simmons, C. A. Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. Am. J. Pathol. 174, 1109\u20131119. https:\/\/doi.org\/10.2353\/ajpath.2009.080750 (2009).","journal-title":"Am. J. Pathol."},{"key":"31070_CR35","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","volume":"60","author":"MR Dweck","year":"2012","unstructured":"Dweck, M. R., Boon, N. A. & Newby, D. E. Calcific aortic stenosis: a disease of the valve and the myocardium. J. Am. Coll. Cardiol. 60, 1854\u20131863. https:\/\/doi.org\/10.1016\/j.jacc.2012.02.093 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"31070_CR36","doi-asserted-by":"publisher","first-page":"H1123","DOI":"10.1152\/ajpheart.00651.2019","volume":"319","author":"A Jenke","year":"2020","unstructured":"Jenke, A. et al. Transforming growth factor-beta1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model. Am. J. Physiol. Heart Circ. Physiol. 319, H1123\u2013H1141. https:\/\/doi.org\/10.1152\/ajpheart.00651.2019 (2020).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"31070_CR37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fendo.2019.00294","volume":"10","author":"G Vial","year":"2019","unstructured":"Vial, G., Detaille, D. & Guigas, B. Role of mitochondria in the Mechanism(s) of action of Metformin. Front. Endocrinol. (Lausanne). 10, 294. https:\/\/doi.org\/10.3389\/fendo.2019.00294 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"31070_CR38","doi-asserted-by":"publisher","first-page":"C1131","DOI":"10.1152\/ajpcell.00186.2023","volume":"325","author":"J Maurer","year":"2023","unstructured":"Maurer, J. et al. Redox state and altered pyruvate metabolism contribute to a dose-dependent metformin-induced lactate production of human myotubes. Am. J. Physiol. Cell. Physiol. 325, C1131\u2013C1143. https:\/\/doi.org\/10.1152\/ajpcell.00186.2023 (2023).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"31070_CR39","first-page":"353","volume":"14","author":"P Mathieu","year":"2005","unstructured":"Mathieu, P. et al. Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. J. Heart Valve Dis. 14, 353\u2013357 (2005).","journal-title":"J. Heart Valve Dis."},{"key":"31070_CR40","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/ATVBAHA.107.144824","volume":"27","author":"M Scatena","year":"2007","unstructured":"Scatena, M., Liaw, L. & Giachelli, C. M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc Biol. 27, 2302\u20132309. https:\/\/doi.org\/10.1161\/ATVBAHA.107.144824 (2007).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"31070_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/ATVBAHA.118.311577","volume":"39","author":"ZSY Lok","year":"2019","unstructured":"Lok, Z. S. Y. & Lyle, A. N. Osteopontin in vascular disease. Arterioscler. Thromb. Vasc Biol. 39, 613\u2013622. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311577 (2019).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"31070_CR42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bbrc.2008.08.034","volume":"375","author":"I Kanazawa","year":"2008","unstructured":"Kanazawa, I., Yamaguchi, T., Yano, S., Yamauchi, M. & Sugimoto, T. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression. Biochem. Bioph Res. Co. 375, 414\u2013419. https:\/\/doi.org\/10.1016\/j.bbrc.2008.08.034 (2008).","journal-title":"Biochem. Bioph Res. Co."},{"key":"31070_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00223-018-0468-3","volume":"104","author":"Q Liu","year":"2019","unstructured":"Liu, Q. et al. Metformin alleviates the bone loss induced by ketogenic diet: an in vivo study in mice. Calcif Tissue Int. 104, 59\u201369. https:\/\/doi.org\/10.1007\/s00223-018-0468-3 (2019).","journal-title":"Calcif Tissue Int."},{"key":"31070_CR44","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1002\/jcp.30887","volume":"237","author":"K Phadwal","year":"2022","unstructured":"Phadwal, K. et al. Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor. J. Cell. Physiol. 237, 4303\u20134316. https:\/\/doi.org\/10.1002\/jcp.30887 (2022).","journal-title":"J. Cell. Physiol."},{"key":"31070_CR45","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1210\/en.2013-1002","volume":"154","author":"X Cao","year":"2013","unstructured":"Cao, X. et al. Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology 154, 3680\u20133689. https:\/\/doi.org\/10.1210\/en.2013-1002 (2013).","journal-title":"Endocrinology"},{"key":"31070_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00441-011-1189-3","volume":"347","author":"I Toma","year":"2012","unstructured":"Toma, I. & McCaffrey, T. A. Transforming growth factor-beta and atherosclerosis: interwoven atherogenic and atheroprotective aspects. Cell. Tissue Res. 347, 155\u2013175. https:\/\/doi.org\/10.1007\/s00441-011-1189-3 (2012).","journal-title":"Cell. Tissue Res."},{"key":"31070_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2015.07.008","volume":"242","author":"J Hjortnaes","year":"2015","unstructured":"Hjortnaes, J. et al. Valvular interstitial cells suppress calcification of valvular endothelial cells. Atherosclerosis 242, 251\u2013260. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.07.008 (2015).","journal-title":"Atherosclerosis"},{"key":"31070_CR48","doi-asserted-by":"publisher","first-page":"204173141772464","DOI":"10.1177\/2041731417724640","volume":"8","author":"YM Kook","year":"2017","unstructured":"Kook, Y. M., Jeong, Y., Lee, K. & Koh, W. G. Design of biomimetic cellular scaffolds for co-culture system and their application. J. Tissue Eng. 8, 2041731417724640. https:\/\/doi.org\/10.1177\/2041731417724640 (2017).","journal-title":"J. Tissue Eng."},{"key":"31070_CR49","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1096\/fj.201701326R","volume":"32","author":"A Weber","year":"2018","unstructured":"Weber, A. et al. Enzymes of the purinergic signaling system exhibit diverse effects on the degeneration of valvular interstitial cells in a 3-D microenvironment. FASEB J. 32, 4356\u20134369. https:\/\/doi.org\/10.1096\/fj.201701326R (2018).","journal-title":"FASEB J."},{"key":"31070_CR50","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/eurheartj\/ehi248","volume":"26","author":"O Fondard","year":"2005","unstructured":"Fondard, O. et al. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur. Heart J. 26, 1333\u20131341. https:\/\/doi.org\/10.1093\/eurheartj\/ehi248 (2005).","journal-title":"Eur. Heart J."},{"key":"31070_CR51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/PAI.0000000000000144","volume":"24","author":"I Perrotta","year":"2016","unstructured":"Perrotta, I., Sciangula, A., Aquila, S. & Mazzulla, S. Matrix Metalloproteinase-9 expression in calcified human aortic valves: A Histopathologic, Immunohistochemical, and ultrastructural study. Appl. Immunohistochem. Mol. Morphol. 24, 128\u2013137. https:\/\/doi.org\/10.1097\/PAI.0000000000000144 (2016).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"31070_CR52","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.carpath.2015.12.002","volume":"25","author":"S Masjedi","year":"2016","unstructured":"Masjedi, S., Amarnath, A., Baily, K. M. & Ferdous, Z. Comparison of calcification potential of valvular interstitial cells isolated from individual aortic valve cusps. Cardiovasc. Pathol. 25, 185\u2013194. https:\/\/doi.org\/10.1016\/j.carpath.2015.12.002 (2016).","journal-title":"Cardiovasc. Pathol."},{"key":"31070_CR53","first-page":"1","volume":"6","author":"FJ Schoen","year":"1997","unstructured":"Schoen, F. J. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J. Heart Valve Dis. 6, 1\u20136 (1997).","journal-title":"J. Heart Valve Dis."},{"key":"31070_CR54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2005.11.034","volume":"189","author":"HA Eriksen","year":"2006","unstructured":"Eriksen, H. A. et al. Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis. Atherosclerosis 189, 91\u201398. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.11.034 (2006).","journal-title":"Atherosclerosis"},{"key":"31070_CR55","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00380-022-02164-2","volume":"38","author":"LR Simon","year":"2023","unstructured":"Simon, L. R., Scott, A. J., Rios, F., Zembles, L., Masters, K. S. & J. & Cellular-scale sex differences in extracellular matrix remodeling by valvular interstitial cells. Heart Vessels. 38, 122\u2013130. https:\/\/doi.org\/10.1007\/s00380-022-02164-2 (2023).","journal-title":"Heart Vessels"},{"key":"31070_CR56","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova, M. M. & Shaw, R. J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell. Biol. 13, 1016\u20131023. https:\/\/doi.org\/10.1038\/ncb2329 (2011).","journal-title":"Nat. Cell. Biol."},{"key":"31070_CR57","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmet.2016.09.003","volume":"24","author":"CS Zhang","year":"2016","unstructured":"Zhang, C. S. et al. Metformin activates AMPK through the lysosomal pathway. Cell. Metab. 24, 521\u2013522. https:\/\/doi.org\/10.1016\/j.cmet.2016.09.003 (2016).","journal-title":"Cell. Metab."},{"key":"31070_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","volume":"25","author":"JJ Howell","year":"2017","unstructured":"Howell, J. J. et al. Metformin inhibits hepatic mTORC1 signaling via Dose-Dependent mechanisms involving AMPK and the TSC complex. Cell. Metab. 25, 463\u2013471. https:\/\/doi.org\/10.1016\/j.cmet.2016.12.009 (2017).","journal-title":"Cell. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31070-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31070-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31070-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:10:51Z","timestamp":1766067051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31070-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["31070"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31070-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44057"}}